44 related articles for article (PubMed ID: 11724329)
1. Expression of HLA-DR is reduced in tumor infiltrating immune cells (TIICs) and regional lymph nodes of non-small-cell lung carcinomas. A putative mechanism of tumor-induced immunosuppression?
Foukas PG; Tsilivakos V; Zacharatos P; Mariatos G; Moschos S; Syrianou A; Asimacopoulos PJ; Bramis J; Fotiadis C; Kittas C; Gorgoulis VG
Anticancer Res; 2001; 21(4A):2609-15. PubMed ID: 11724329
[TBL] [Abstract][Full Text] [Related]
2. HLA class I antigen expression is associated with a favorable prognosis in early stage non-small cell lung cancer.
Kikuchi E; Yamazaki K; Torigoe T; Cho Y; Miyamoto M; Oizumi S; Hommura F; Dosaka-Akita H; Nishimura M
Cancer Sci; 2007 Sep; 98(9):1424-30. PubMed ID: 17645781
[TBL] [Abstract][Full Text] [Related]
3. Antitumor response of regional lymph node lymphocytes in human lung cancer.
Takenoyama M; Yasumoto K; Harada M; Sugimachi K; Nomoto K
Cancer Immunol Immunother; 1998 Dec; 47(4):213-20. PubMed ID: 9875674
[TBL] [Abstract][Full Text] [Related]
4. Quantitative tissue analysis and role of myeloid cells in non-small cell lung cancer.
Henick BS; Villarroel-Espindola F; Datar I; Sanmamed MF; Yu J; Desai S; Li A; Aguirre-Ducler A; Syrigos K; Rimm DL; Chen L; Herbst RS; Schalper KA
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35793873
[TBL] [Abstract][Full Text] [Related]
5. Inhaled particulate accumulation with age impairs immune function and architecture in human lung lymph nodes.
Ural BB; Caron DP; Dogra P; Wells SB; Szabo PA; Granot T; Senda T; Poon MML; Lam N; Thapa P; Lee YS; Kubota M; Matsumoto R; Farber DL
Nat Med; 2022 Dec; 28(12):2622-2632. PubMed ID: 36411343
[TBL] [Abstract][Full Text] [Related]
6. Strong HLA-DR antigen expression on cancer cells relates to better prognosis of colorectal cancer patients: Possible involvement of c-myc suppression by interferon-gamma in situ.
Matsushita K; Takenouchi T; Shimada H; Tomonaga T; Hayashi H; Shioya A; Komatsu A; Matsubara H; Ochiai T
Cancer Sci; 2006 Jan; 97(1):57-63. PubMed ID: 16367922
[TBL] [Abstract][Full Text] [Related]
7. Expression of MHC class II antigens in human lung cancer cells.
Kamma H; Yazawa T; Ogata T; Horiguchi H; Iijima T
Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 60(6):407-12. PubMed ID: 1683057
[TBL] [Abstract][Full Text] [Related]
8. EMAP II Expression Is Increased on Peripheral Blood Cells from Non-Hodgkin Lymphoma.
Saber MM
J Immunol Res; 2022; 2022():7219207. PubMed ID: 36132984
[TBL] [Abstract][Full Text] [Related]
9. Single B Cell Gene Co-Expression Networks Implicated in Prognosis, Proliferation, and Therapeutic Responses in Non-Small Cell Lung Cancer Bulk Tumors.
Ye Q; Guo NL
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804895
[TBL] [Abstract][Full Text] [Related]
10. Human leukocyte antigen class II-based immune risk model for recurrence evaluation in stage I-III small cell lung cancer.
Chen P; Zhao L; Wang H; Zhang L; Zhang W; Zhu J; Yu J; Zhao S; Li W; Sun C; Wu C; He Y; Zhou C
J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34362829
[TBL] [Abstract][Full Text] [Related]
11. The landscape of immune checkpoints expression in non-small cell lung cancer: a narrative review.
Liu Y; Chen P; Wang H; Wu S; Zhao S; He Y; Zhou C; Hirsch FR
Transl Lung Cancer Res; 2021 Feb; 10(2):1029-1038. PubMed ID: 33718041
[TBL] [Abstract][Full Text] [Related]
12. Genomics-based immuno-oncology: bridging the gap between immunology and tumor biology.
DiNatale RG; Hakimi AA; Chan TA
Hum Mol Genet; 2020 Oct; 29(R2):R214-R225. PubMed ID: 33029628
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic applications of the selective high affinity ligand drug SH7139 extend beyond non-Hodgkin's lymphoma to many other types of solid cancers.
Balhorn R; Balhorn MC
Oncotarget; 2020 Sep; 11(35):3315-3349. PubMed ID: 32934776
[TBL] [Abstract][Full Text] [Related]
14. Characterising the prognostic potential of HLA-DR during colorectal cancer development.
Dunne MR; Phelan JJ; Michielsen AJ; Maguire AA; Dunne C; Martin P; Noonan S; Tosetto M; Geraghty R; Fennelly D; Sheahan K; Ryan EJ; O'Sullivan J
Cancer Immunol Immunother; 2020 Aug; 69(8):1577-1588. PubMed ID: 32306077
[TBL] [Abstract][Full Text] [Related]
15. HLA-DR expression in tumor epithelium is an independent prognostic indicator in esophageal adenocarcinoma patients.
Dunne MR; Michielsen AJ; O'Sullivan KE; Cathcart MC; Feighery R; Doyle B; Watson JA; O'Farrell NJ; Ravi N; Kay E; Reynolds JV; Ryan EJ; O'Sullivan J
Cancer Immunol Immunother; 2017 Jul; 66(7):841-850. PubMed ID: 28315927
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of immune evasion and current status of checkpoint inhibitors in non-small cell lung cancer.
Qin A; Coffey DG; Warren EH; Ramnath N
Cancer Med; 2016 Sep; 5(9):2567-78. PubMed ID: 27416962
[TBL] [Abstract][Full Text] [Related]
17. Tumor associated macrophages polarization dictates the efficacy of BCG instillation in non-muscle invasive urothelial bladder cancer.
Suriano F; Santini D; Perrone G; Amato M; Vincenzi B; Tonini G; Muda A; Boggia S; Buscarini M; Pantano F
J Exp Clin Cancer Res; 2013 Nov; 32(1):87. PubMed ID: 24423367
[TBL] [Abstract][Full Text] [Related]
18. The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients.
Pantano F; Berti P; Guida FM; Perrone G; Vincenzi B; Amato MM; Righi D; Dell'aquila E; Graziano F; Catalano V; Caricato M; Rizzo S; Muda AO; Russo A; Tonini G; Santini D
J Cell Mol Med; 2013 Nov; 17(11):1415-21. PubMed ID: 24283947
[TBL] [Abstract][Full Text] [Related]
19. The tissue microlocalisation and cellular expression of CD163, VEGF, HLA-DR, iNOS, and MRP 8/14 is correlated to clinical outcome in NSCLC.
Ohri CM; Shikotra A; Green RH; Waller DA; Bradding P
PLoS One; 2011; 6(7):e21874. PubMed ID: 21799753
[TBL] [Abstract][Full Text] [Related]
20. Alveolar macrophage function is altered in patients with lung cancer.
Pouniotis DS; Plebanski M; Apostolopoulos V; McDonald CF
Clin Exp Immunol; 2006 Feb; 143(2):363-72. PubMed ID: 16412062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
